Demand for GLP-1 obesity drugs has been strong in the month and a half since the Medicare Bridge program launched, according to two of the biggest pharmacy chains. Eligible beneficiaries can get the medicines for $50 a month.
×
Demand for GLP-1 obesity drugs has been strong in the month and a half since the Medicare Bridge program launched, according to two of the biggest pharmacy chains. Eligible beneficiaries can get the medicines for $50 a month.